Tislelizumab Antibody
Tislelizumab (BGB-A317) is an anti-PD-1 IgG4 monoclonal antibody engineered to minimize FcγR binding on macrophages. It exhibits antitumor activity and is a research tool for studying advanced squamous non-small cell lung cancer in both in vitro assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
VDT-482, PD-L1, PDL1, PD1/PDL1, PD1, PD-1, BGB-A317
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
4.21 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC801037-500 1x 500 µL
CD44 Standard (DF1485), CF680 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042308-500 1x 500 µL
HSP27 (Heat Shock Protein 27) (rHSPB1/774), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681025-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26 + 57), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040908-500 1x 500 µL
Tyrosinase (T311 + OCA1/812), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 